Cargando…

Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association

BACKGROUND: Health care transition (HCT) is a period of high vulnerability for patients with chronic childhood diseases, particularly when patients shift from a pediatric to an adult care setting. An increasing number of patients with Kawasaki disease (KD) who develop medium and large coronary arter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahdah, Nagib, Kung, Samuel C., Friedman, Kevin G., Marelli, Ariane, Gordon, John B., Belay, Ermias D., Baker, Annette L., Kazi, Dhruv S., White, Patience H., Tremoulet, Adriana H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	AHA Scientific Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751858/ https://www.ncbi.nlm.nih.gov/pubmed/34632822 http://dx.doi.org/10.1161/JAHA.121.023310

Ejemplares similares

Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
por: Levine, Glenn N., et al.
Publicado: (2017)

Caregiver Influences on Eating Behaviors in Young Children: A Scientific Statement From the American Heart Association
por: Wood, Alexis C., et al.
Publicado: (2020)

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association
por: Baker‐Smith, Carissa M., et al.
Publicado: (2021)

Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association
por: Cornwell, William K., et al.
Publicado: (2021)

Self‐Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association
por: Riegel, Barbara, et al.
Publicado: (2017)

Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association
por: Rudd, Nancy A., et al.
Publicado: (2020)

Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association
por: John, Anitha S., et al.
Publicado: (2022)

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association
por: Lopez, Keila N., et al.
Publicado: (2022)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Scientific Statements
Publicado: (2013)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Statement on additional scientific evidence in relation to the essential composition of total diet replacement for weight control
por: Castenmiller, Jacqueline, et al.
Publicado: (2021)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(®) trial
por: Fitchett, David, et al.
Publicado: (2016)

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes
por: Hill, James O., et al.
Publicado: (2013)

Statement of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the design and conduct of groundwater monitoring studies supporting groundwater exposure assessments of pesticides
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2023)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
por: Marco, Maria L., et al.
Publicado: (2021)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
por: Swanson, Kelly S., et al.
Publicado: (2020)

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
por: Salminen, Seppo, et al.
Publicado: (2021)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Statement concerning the review of the approval of the active substance ipconazole
Publicado: (2022)

Statement concerning the review of the approval of the active substance pirimicarb
Publicado: (2023)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
por: Dahdah, Nagib, et al.
Publicado: (2013)

Statement on the BfR opinion regarding the toxicity of 2‐chloroethanol
por: Borroto, Jorge, et al.
Publicado: (2022)

Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
por: de Ferranti, Sarah D., et al.
Publicado: (2014)

Nonnutritive Sweeteners: Current Use and Health Perspectives: A Scientific Statement from the American Heart Association and the American Diabetes Association
por: Gardner, Christopher, et al.
Publicado: (2012)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_opgvc8c583vosnmo94alt04po1